Functional tests verified that HCP5 could function as an oncogene in osteosarcoma and was activated by the transcription factor 1 (SP1), convincing that SP1 induced the up-regulation of HCP5, which impacted the development of osteosarcoma (30). The gene discussed is HCP5; the disease is osteosarcoma.